We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+0.76%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$706B
AUM Growth
-$5.71B
Cap. Flow
-$2.17B
Cap. Flow %
-0.31%
Top 10 Hldgs %
21.49%
Holding
2,592
New
52
Increased
1,566
Reduced
801
Closed
74

Sector Composition

Rank Sector Weight
1 Technology 20.27%
2 Healthcare 16.18%
3 Financials 13.98%
4 Consumer Discretionary 13.5%
5 Industrials 10.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSMT icon
1451
Pricesmart
PSMT
$5.49B
$3.22M ﹤0.01%
45,286
-3,398
-7% -$206K
KTB icon
1452
Kontoor Brands
KTB
$4.51B
$3.21M ﹤0.01%
91,580
+3,508
+4% +$114K
FTSV
1453
DELISTED
Forty Seven, Inc. Common Stock
FTSV
$3.21M ﹤0.01%
500,155
-209,641
-30% -$1.72M
MYOV
1454
DELISTED
Myovant Sciences Ltd.
MYOV
$3.19M ﹤0.01%
613,315
-473,578
-44% -$3.51M
LIND icon
1455
Lindblad Expeditions
LIND
$2.24B
$3.16M ﹤0.01%
188,640
+109
+0.1% +$1.98K
PHAS
1456
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$3.13M ﹤0.01%
750,878
-45,358
-6% -$362K
LSXMK
1457
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$3.13M ﹤0.01%
97,918
-20,396
-17% -$634K
LOMA
1458
Loma Negra
LOMA
$1.13B
$3.12M ﹤0.01%
542,008
-5,008,398
-90% -$42.1M
ARQL
1459
DELISTED
Arqule Inc
ARQL
$3.1M ﹤0.01%
432,833
-637,177
-60% -$5.99M
ITT icon
1460
ITT
ITT
$19.4B
$3.09M ﹤0.01%
50,540
+6,201
+14% +$374K
STWD icon
1461
Starwood Property Trust
STWD
$6.09B
$3.08M ﹤0.01%
127,303
+1,129
+0.9% +$26.6K
EME icon
1462
Emcor
EME
$36.7B
$3.08M ﹤0.01%
35,741
+1,283
+4% +$109K
Z icon
1463
Zillow
Z
$8.08B
$3.07M ﹤0.01%
103,074
-1,148
-1% -$45.7K
HAPN
1464
Happen Inc
HAPN
$2.27B
$3.07M ﹤0.01%
234,880
-126,836
-35% -$1.83M
EB
1465
DELISTED
Eventbrite
EB
$3.07M ﹤0.01%
173,264
+5,879
+4% +$103K
CBSH icon
1466
Commerce Bancshares
CBSH
$8.61B
$3.06M ﹤0.01%
71,001
+4,517
+7% +$188K
JHG
1467
DELISTED
Janus Henderson
JHG
$3.06M ﹤0.01%
136,259
+538
+0.4% +$11.2K
OC icon
1468
Owens Corning
OC
$12.3B
$3.05M ﹤0.01%
48,243
-315
-0.6% -$18K
AWR icon
1469
American States Water
AWR
$3.49B
$3.03M ﹤0.01%
33,676
+197
+0.6% +$16.5K
WH icon
1470
Wyndham Hotels & Resorts
WH
$5.49B
$3.02M ﹤0.01%
58,394
+431
+0.7% +$23.6K
AVA icon
1471
Avista
AVA
$3.23B
$3.01M ﹤0.01%
62,129
-5,592
-8% -$260K
NWS icon
1472
News Corp Class B
NWS
$17.7B
$2.98M ﹤0.01%
208,185
+315
+0.2% +$4.42K
MDCO
1473
DELISTED
Medicines Co
MDCO
$2.98M ﹤0.01%
59,502
-1,733
-3% -$69.1K
AZTA icon
1474
Azenta
AZTA
$1.47B
$2.97M ﹤0.01%
80,198
+1,136
+1% +$41.2K
SBRA icon
1475
Sabra Healthcare REIT
SBRA
$5.15B
$2.97M ﹤0.01%
129,205
+1,073
+0.8% +$22.9K

Similar funds

T. Rowe Price Associates's Q3 2019 Portfolio in Review

As of Q3 2019, T. Rowe Price Associates held 2,592 positions worth $706B, down 0.8% from $712B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Trading was light in Q3 2019: portfolio turnover was 4.9%. T. Rowe Price Associates opened 52 new positions and exited 74, leaving the 2,592-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q3 2019 buy was The Southern Company: 9,440,159 shares worth $502M.
  • T. Rowe Price Associates added most to Fidelity National Information Services in Q3 2019, an estimated $3.15B increase.
  • T. Rowe Price Associates's biggest Q3 2019 reduction was Bank of America, cutting an estimated $1.43B.
  • T. Rowe Price Associates fully exited Worldpay, Inc. in Q3 2019, selling an estimated $3.23B.
  • T. Rowe Price Associates's ten largest holdings make up 21% of its $706B portfolio in Q3 2019.
  • T. Rowe Price Associates opened 52 new positions and closed 74 in Q3 2019.
  • T. Rowe Price Associates's portfolio value fell 0.8% quarter-over-quarter to $706B.

Based on T. Rowe Price Associates's 13F filing for Q3 2019, filed 14 Nov 2019.